Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 54
- Medical
AMP exclusive enters cannabis extract distribution agreement in Germany
The three-year agreement will see AMP become the exclusive distribution partner for Australia-based Little Green Pharma.
- Hemp Industry
Canxchange launches new trading system for the cannabis market
Canxchange is introducing more transparency, liquidity and efficiency to the growing cannabis market through its new platform.
- Pharmaceutical
Oxford Cannabinoid Technologies sees positive progression
Oxford Cannabinoid Technologies Holdings has begun 2022 with a positive start and has announced a new date for the start of its Phase I trial.
- Medical
AMP Alternative Medical Products begins Dronabinol sales in Germany
The company is a medical cannabis subsidiary of Greenrise Global Brands.
- Uncategorized
AMP Alternative Medical Products beginnt mit dem Vertrieb von Dronabinol in Deutschland
Das Unternehmen ist eine medizinische Cannabis-Tochtergesellschaft von Greenrise Global Brands.
- Policy & Regulation
Mayor of London urged to drop cannabis diversion pilot
The pilot would “send the wrong message to young Londoners” say MPs.
- CBD Market
CBD-brand MYO launches in Boots across the UK
MYO will be available in 838 Boots stores across the country.
- Policy & Regulation
New report lays out cannabis social equity principles for UK
The new report for the UK’s legal cannabis industry has been published by the national centre of expertise on drugs and drugs law in the UK, Release.
- Cultivation
Flowr Corporation says strategy in Portugal paying dividends
Harvesting of high-THC strains is expected at its subsidiary’s Portugal facility by the end of January 2022.
- CBD Market
New narcotics ruling in France raises further questions on CBD decree
A new ruling in France has made an official definition of narcotics.
- Medical
Agreement aims to approve first cannabis vaporiser for European patients
A collaboration will see studies undertaken to prove the efficacy and safety of the device.
- Adult-Use
Tilray sees ongoing progress across Europe
The company has announced a new parent name and a profitable second fiscal quarter, with ongoing progress across the EU.
